Results 141 to 150 of about 41,093 (223)
Malaria vaccination and rebound malaria [PDF]
Dicko, Alassane, Greenwood, Brian
openaire +2 more sources
Immune mechanisms targeting malaria transmission: opportunities for vaccine development
Introduction Malaria continues to remain a major global health problem with nearly a quarter of a billion clinical cases and more than 600,000 deaths in 2022.
Geetha P. Bansal, Nirbhay Kumar
doaj +1 more source
Different protozoan parasites are the causative agents of tropical diseases, including malaria, toxoplasmosis, leishmaniasis, and Chagas disease (CD), which, altogether, affect over 300 million people throughout the world.
Marina Ferreira Batista-Zauli +6 more
doaj +1 more source
Current approaches to malaria vaccines. [PDF]
Duffy PE.
europepmc +1 more source
Atomic clarity: how structural biology is shaping blood-stage malaria vaccines. [PDF]
Nema S +5 more
europepmc +1 more source
B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings. [PDF]
Bundi CK +22 more
europepmc +2 more sources
Malaria vaccines: Current developments and immunological insights. [PDF]
Verma A +6 more
europepmc +1 more source
Five decades of clinical assessment of whole-sporozoite malaria vaccines. [PDF]
Nunes-Cabaço H, Moita D, Prudêncio M.
europepmc +1 more source
Provincial stratification and equity-weighted cost-effectiveness of malaria vaccines in Zambia under climate variability. [PDF]
Phiri AE.
europepmc +1 more source
Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants. [PDF]
Bonam SR +4 more
europepmc +1 more source

